345 related articles for article (PubMed ID: 17654055)
21. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
22. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
23. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
24. A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia.
Sagmeister M; Oec L; Gmür J
Blood; 1999 May; 93(9):3124-6. PubMed ID: 10216111
[TBL] [Abstract][Full Text] [Related]
25. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
26. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
[TBL] [Abstract][Full Text] [Related]
27. Treatment of severe thrombocytopenia with IL-11 in children with Wiskott-Aldrich syndrome.
Braithwaite K; Abu-Ghosh A; Anderson L; Cairo MS
J Pediatr Hematol Oncol; 2002 May; 24(4):323-6. PubMed ID: 11972106
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of pregnancy complicated with severe thrombocytopenia].
Wang DP; Liang MY; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):401-5. PubMed ID: 21029587
[TBL] [Abstract][Full Text] [Related]
29. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
[TBL] [Abstract][Full Text] [Related]
30. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.
Salama A; Kiesewetter H; Kalus U; Movassaghi K; Meyer O
Thromb Haemost; 2008 Nov; 100(5):762-5. PubMed ID: 18989518
[TBL] [Abstract][Full Text] [Related]
31. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome.
Mathew P; Conley ME
Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726
[TBL] [Abstract][Full Text] [Related]
32. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
33. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.
Okuya M; Kurosawa H; Kubota T; Endoh K; Ogiwara A; Nonoyama S; Hagisawa S; Sato Y; Matsushita T; Fukushima K; Sugita K; Sato T; Arisaka O
Bone Marrow Transplant; 2010 Mar; 45(3):607-9. PubMed ID: 19684625
[No Abstract] [Full Text] [Related]
35. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
36. A consistent approach to platelet transfusion in the NICU.
Del Vecchio A; Motta M; Radicioni M; Christensen RD
J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
[TBL] [Abstract][Full Text] [Related]
37. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
38. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
39. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
40. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates.
Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA
Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
